» Articles » PMID: 15335440

Frontotemporal Dementia: Genetics and Genetic Counseling Dilemmas

Overview
Journal Neurologist
Specialty Neurology
Date 2004 Sep 1
PMID 15335440
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Frontotemporal dementia (FTD) is a neurodegenerative disease with early symptoms of personality change and/or language disorder. Approximately 40% of individuals with FTD have a family history of dementia; however, in our experience, less than 10% have clear autosomal dominant inheritance. Mutations in the microtubule-associated protein tau (MAPT) gene have been reported in up to 50% of hereditary cases, but are unusual except in families with more than 3 individuals with FTD. The genetics of FTD is complicated by clinical heterogeneity, variable expression, phenocopies, misdiagnoses, and lost family histories. The objective of this paper is to enable physicians to recognize hereditary patterns and genetic concerns of FTD families and to understand genetic counseling strategies.

Review Summary: The complexity of FTD genetics and genetic counseling are illustrated using 4 case histories. Case 1 demonstrates the difficulty obtaining a reliable FTD family history. Case 2 illustrates how psychiatric phenocopies can make family linkage studies difficult. The lack of genotype and phenotype correlation and issues of predictive genetic testing within FTD families are the subject of case 3, and case 4 shows how normal aging language difficulties and cognitive changes can be misinterpreted when a family history of dementia is present.

Conclusions: Physicians seeing patients with possible FTD should be aware of the risk of a genetic etiology. A 3-generation family history should be obtained with attention to neurologic, psychiatric, and behavioral symptoms. Variable expression and phenocopies are confounding factors when assessing a possible genetic etiology. Referral of the patient and family for genetic counseling is recommended.

Citing Articles

Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.

Perneel J, Rademakers R Acta Neuropathol. 2022; 144(5):807-819.

PMID: 36056242 PMC: 9547799. DOI: 10.1007/s00401-022-02486-5.


Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.

Jiang Y, Cao Q, Sawaya M, Abskharon R, Ge P, DeTure M Nature. 2022; 605(7909):304-309.

PMID: 35344984 PMC: 9844993. DOI: 10.1038/s41586-022-04670-9.


Analysis of Heritability Across the Clinical Phenotypes of Frontotemporal Dementia and the Frequency of the C9ORF72 in a Colombian Population.

Lopez-Caceres A, Velasco-Rueda M, Garcia-Cifuentes E, Zarante I, Matallana D Front Neurol. 2021; 12:681595.

PMID: 34526954 PMC: 8435669. DOI: 10.3389/fneur.2021.681595.


and the Care of the Patient With ALS or FTD: Progress and Recommendations After 10 Years.

Roggenbuck J Neurol Genet. 2021; 7(1):e542.

PMID: 33575483 PMC: 7862089. DOI: 10.1212/NXG.0000000000000542.


Case Report: Early-Onset Behavioral Variant Frontotemporal Dementia in Patient With Retrotransposed Full-Length Transcript of Variant 5.

Castro M, Venkateswaran N, Peters S, Deyle D, Bower M, Koob M Front Neurol. 2021; 11:600468.

PMID: 33408686 PMC: 7779795. DOI: 10.3389/fneur.2020.600468.